An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

February 1, 2020

Study Completion Date

August 31, 2021

Conditions
Larynx CancerLarynx Carcinoma
Interventions
OTHER

Obtaining blood samples

Blood samples were obtained at time of diagnosis and will be analyzed for the levels of biomarker candidate molecules.

Trial Locations (1)

06100

Hacettepe University Cancer Institute, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT05217147 - An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma | Biotech Hunter | Biotech Hunter